PrEP

Gov’t approves use of HIV injectables in Uganda

KAMPALA, January 5, 2025 — The National Drug Authority [NDA] has approved the use of lenacapavir, a twice-yearly HIV prevention [PrEP] injection manufactured by Gilead Sciences, a U.S.-based company. The approval is…